Meanwhile, we also found numerous other mutations in genes such as TP53, FLT3, ASXL1, SETBP1, CEBPA and CBL, suggesting that CML may be more highly heterogeneous than previously appreciated. The gene discussed is FLT3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.